Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) EBITDA (2022 - 2023)

Historic EBITDA for Bluejay Diagnostics (BJDX) over the last 2 years, with Q2 2023 value amounting to -$2.9 million.

  • Bluejay Diagnostics' EBITDA fell 4622.81% to -$2.9 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$10.8 million, marking a year-over-year change of. This contributed to the annual value of -$7.2 million for FY2024, which is 3046.78% up from last year.
  • Bluejay Diagnostics' EBITDA amounted to -$2.9 million in Q2 2023, which was down 4622.81% from -$2.7 million recorded in Q1 2023.
  • Bluejay Diagnostics' 5-year EBITDA high stood at -$2.0 million for Q2 2022, and its period low was -$2.9 million during Q2 2023.